Why are folks shocked about any of this? It was obvious costs were going to be high with the relocation activities and setting up a manufacturing plant.
They have approval to manufacture and export. This is very significant and also empowers them to create and launch new products more simply and cheaply than if they were using a contractor for manufacturing. They truly can do proof of concept products without it being a huge financial burden.
Pet food applications? Yoghurt powders? They intend to launch new products around these? That is interesting.
They also intend to, and already have earn't a bit of extra dosh doing non K12/M18 related manufacturing jobs for other folks.
They are finally getting ready to move into Australia. Good to hear!
Sinopharm are taking the product seriously and are spending money on three clinical trials.
The Europeans are spending money on trials...including M18 trials.
Trials are being done in NZ and if positive will give significant exposure to the product...far more than Blis could afford to spend marketing their product. If positive it is forseeable that the product will be given to students in many or all low decile schools.
I don't find the result disappointing in the short-term or any other term. Did anybody else to the sums regarding stocking up China? I did using $5 revenue per bottle times 20 bottles per pharmacy. That is $60,000. I would have been surprised if revenue exceeded 100k and was more expecting the value to be even less than half of that. Perhaps the order hadn't even been placed by the end of September? In a nutshell I wasn't expecting the announcement to result in an instant fortune for the company.